Gilead Sciences Inc (GILD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2014 | 03-2014 | 12-2013 | 09-2013 | 06-2013 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 5,873,000 | 2,223,000 | 3,057,000 | 2,270,544 | 1,485,328 |
| Depreciation Amortization | 507,000 | 241,000 | 345,000 | 216,745 | 147,503 |
| Income taxes - deferred | -53,000 | -3,000 | -98,000 | -12,400 | 9,974 |
| Accounts receivable | -1,332,000 | -1,118,000 | -315,000 | -226,308 | -181,266 |
| Accounts payable and accrued liabilities | -90,000 | -20,000 | -98,000 | 23,131 | 64,831 |
| Other Working Capital | -770,000 | -982,000 | -562,000 | -370,727 | -179,391 |
| Other Operating Activity | 1,618,000 | 1,227,000 | 776,000 | 477,216 | 278,126 |
| Operating Cash Flow | $5,753,000 | $1,568,000 | $3,105,000 | $2,378,201 | $1,625,105 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -393,000 | 3,000 | 315,000 | 29,190 | 42 |
| PPE Investments | -255,000 | -164,000 | -190,000 | -121,310 | -84,130 |
| Net Acquisitions | N/A | N/A | -379,000 | -378,645 | -378,645 |
| Investing Cash Flow | $-648,000 | $-161,000 | $-254,000 | $-470,765 | $-462,733 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 5,278,000 | 4,569,000 | 2,774,000 | 1,257,869 | 1,205,956 |
| Debt Repayment | -2,465,000 | -1,445,000 | -4,440,000 | -2,224,782 | -2,135,575 |
| Common Stock Issued | 163,000 | 109,000 | 313,000 | 240,671 | 146,342 |
| Common Stock Repurchased | -1,650,000 | -450,000 | -582,000 | -182,259 | -82,239 |
| Other Financing Activity | 187,000 | 101,000 | -609,000 | -790,381 | 108,867 |
| Financing Cash Flow | $1,513,000 | $2,884,000 | $-2,544,000 | $-1,698,882 | $-756,649 |
| Exchange Rate Effect | N/A | N/A | 2,000 | -1,512 | -7,241 |
| Beginning Cash Position | 2,113,000 | 2,113,000 | 1,804,000 | 1,803,694 | 1,803,694 |
| End Cash Position | 8,731,000 | 6,404,000 | 2,113,000 | 2,010,736 | 2,202,176 |
| Net Cash Flow | $6,618,000 | $4,291,000 | $309,000 | $207,042 | $398,482 |
| Free Cash Flow | |||||
| Operating Cash Flow | 5,753,000 | 1,568,000 | 3,105,000 | 2,378,201 | 1,625,105 |
| Capital Expenditure | -255,000 | -164,000 | -190,000 | -121,310 | -84,130 |
| Free Cash Flow | 5,498,000 | 1,404,000 | 2,915,000 | 2,256,891 | 1,540,975 |